ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 569,52
0,88%
Dow Jones
38 599,68
0,03%
DAX
18 073,74
0,30%
Brent Oil
82,745
0,75%
Bitcoin
65 597,00
-1,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) Actualités

PSNL

Personalis (PSNL)

Personalis Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DateHeureSourceTitreSymboleSociété
13/06/202414h00Business WirePersonalis Provides Dial-in and Updated Date for ASCO Highlights Conference CallNASDAQ:PSNLPersonalis Inc
04/06/202422h05Business WireASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy MonitoringNASDAQ:PSNLPersonalis Inc
31/05/202415h05Business WirePersonalis Announces Start of Cancer MRD Testing Commercialization Collaboration with TempusNASDAQ:PSNLPersonalis Inc
22/05/202415h05Business WirePersonalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024NASDAQ:PSNLPersonalis Inc
22/05/202403h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
21/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
17/05/202422h05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/05/202422h01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
24/04/202422h01Business WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/03/202421h01Business WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
28/03/202414h00Business WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
26/03/202414h00Business WirePersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response MonitoringNASDAQ:PSNLPersonalis Inc
28/02/202422h01Business WirePersonalis Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
14/02/202422h01Business WirePersonalis to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
31/01/202422h01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
30/01/202415h00Business WirePersonalis and ClearNote Health Announce Partnership to Advance Epigenomic TechnologyNASDAQ:PSNLPersonalis Inc
29/01/202422h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PSNLPersonalis Inc
16/01/202415h05Business WirePersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling AssayNASDAQ:PSNLPersonalis Inc
10/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
05/01/202415h05Business WirePersonalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash BalanceNASDAQ:PSNLPersonalis Inc
21/12/202323h15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
05/12/202322h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/12/202322h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PSNLPersonalis Inc
04/12/202315h15Business WirePersonalis Extends Cash Position Into 2026, Provides Update on Key InitiativesNASDAQ:PSNLPersonalis Inc
28/11/202322h15Business WirePersonalis and Tempus Enter into a Strategic Collaboration to Advance Cancer TestingNASDAQ:PSNLPersonalis Inc
07/11/202322h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
07/11/202322h01Business WirePersonalis Reports Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
26/10/202314h15Business WirePersonalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in CancerNASDAQ:PSNLPersonalis Inc
24/10/202322h01Business WirePersonalis to Announce Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
21/10/202310h25Business WireAnalysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD TechnologyNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Dernières Valeurs Consultées

NYSE
NKE
Nike
NYSE
DIS
Walt Disney
EU
LR
Legrand
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
EU
CS
Axa
NASDAQ
MSFT
Microsoft
EU
AF
Air FranceKLM
NASDAQ
NVDA
NVIDIA
EU
BEL20
Bel 20
EU
PX1
CAC 40
EU
BN
Danone
EU
VK
Vallourec
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés